Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toripalimab in Combination with FOLFOX for Locally Advanced Colon Cancer
NCT03985891Phase 2Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Dec 2020
- Primary completion
- Jun 2025
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of toripalimab in colon cancer, sponsored by Xiangya Hospital, Central South University. Started Dec 2020; status: recruiting.
02
Drugs
toripalimab
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT03985891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03985891.